Skip to content

Other Income - Net at other companies

Agrify Corporation logo
Agrify CorporationRYM
-$1.64M-483%
Taylor Devices logo
Taylor DevicesTAYD
$351.45K-2.5%
ePlus logo
ePlusPLUS
$0-100%
Oruka Therapeutics, Inc. logo
Oruka Therapeutics, Inc.ORKA
$4.61M+12.9%
Bit Digital logo
Bit DigitalBTBT
-$6.94M-48.7%
CO2 Energy Transition Corp. Common Stock logo
CO2 Energy Transition Corp. Common StockNOEM
$632.15K-12.6%

Other financials

Income statement

See full
Revenue$1.7M
Gross profit$1.3M
Operating income-$28.6M-283%
Net income-$26.6M-244%
EPS (diluted)-$0.27-145%

Balance sheet

See full
Cash & equivalents$2.6M+2,350,466%
Total equity$35.3M-1.0%
Total assets$100.7M+10.1%

Cash flow

See full
Operating cash flow-$3.8M-179%

Valuation

See full
Market cap$60.45M-74.7%

Returns & leverage

See full
Return on equity-119.9%+46.7pp
Current ratio0.5×+0.1×

Where this comes from

Reported directly by Citius Oncology, Inc. in its filing.

Tagged under the XBRL concept us-gaap:NonoperatingIncomeExpense.

The official record: Citius Oncology, Inc.’s 10-Q, filed May 15, 2026, on SEC EDGAR. View the filing →

Ask your AI about Citius Oncology, Inc.'s other income - net.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Citius Oncology, Inc.'s other income - net?
Citius Oncology, Inc. (CTOR) reported other income - net of $1.77M in Q1 2026.
How has Citius Oncology, Inc.'s other income - net changed year-over-year?
Citius Oncology, Inc.'s other income - net increased by 4003.3% year-over-year, from -$45.41K to $1.77M.
What does other income - net mean?
Captures financial gains or losses that fall outside the scope of the company's primary business operations, such as currency fluctuations or asset disposals. This metric helps isolate core operational performance from incidental or non-recurring financial events.